Recent News: Personalized Medicine

Share
Print
and/or
11 News Items found
In the Lab
Illustration of how PU-PET localizes to tumors
Bull’s-Eye: Imaging Technology Could Confirm When a Drug Is Going to the Right Place
Collaborative team advances a new approach for imaging a drug that’s been developed to stop cancer growth.
In the Lab
Illustration of child with kidneys highlighted, cup of urine, and a beam of light.
Analyzing Urine Can Guide the Treatment of Childhood Kidney Tumors
A protein detected in the urine of children with Wilms’ tumor led to the development of a test to improve diagnosis and treatment.
Feature
A calico cat
What Is Epigenetics, and Why Is Everyone Talking about It?
Epigenetics is frequently in the news, but there's lots of confusion about just what it entails.
In the Clinic
Man and woman in white lab coats looking at test tubes
Single-Cell Analysis Enables Researchers to Understand the Differences within Tumors
Scientists are decoding the genetic changes that drive individual cancer cells. This may help them develop more-effective targeted therapies.
In the Lab
MSK investigators Joan Massagué and Anna Obenauf
Outsmarting Cancer’s Survival Skills
A new study led by MSK investigators reveals how some cancer cells become resistant to targeted treatment and suggests what might be done to stop that from happening.
In the Clinic
CAR T cell therapy
CAR T Cell Therapies Are a Growing Area of Research
Cell therapies that use patients’ own immune cells to attack cancer — including CAR T cell therapy, an approach developed at MSK — are a promising and rapidly growing area of research.
MSK at ASCO
Pictured: Jedd Wolchok
Memorial Sloan Kettering’s Expertise in Cancer Immunotherapy Draws Media Focus at 2014 ASCO Meeting
Our experts offer their perspective in major media outlets on recent research into drug- and cell-based immunotherapies for cancer.
Announcement
Pictured: José Baselga
Memorial Sloan Kettering Featured Prominently at Major Cancer Research Meeting
Discoveries made at Memorial Sloan Kettering receive recognition at the 2014 Annual Meeting of the American Association for Cancer Research.
In the Lab
Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell
Molecular Studies Explain Effectiveness of Longtime Treatment for Prostate Cancer
Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.
Announcement
Pictured: American Association of Cancer Research Annual Meeting 2012
Memorial Sloan Kettering Discoveries in Personalized Medicine Highlighted at Major Cancer Research Meeting; Investigators Honored
The American Association for Cancer Research (AACR), the world's oldest and largest professional organization dedicated to advancing cancer research, held its 2012 annual meeting in Chicago.